R01 Research Project Grant
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)
The overarching goal of this Funding Opportunity Announcement (FOA) is to translate basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, hematology, and specific aspects of cystic fibrosis. Additional information concerning programmatic areas at NIDDK is available at: www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx.
|Notice(s) for this Opportunity|
|Letter of Intent Due Date|
30 days prior to the application due date
|Application Due Date|Standard dates
apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications
allowed for this funding opportunity announcement are due on these dates.Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.